Drug Targeting Approaches and Use of Drug Delivery Systems in Management of Cancer

被引:3
作者
Ahuja, Alka [1 ]
Narde, Gurpreet K. [2 ]
Wadi, Nida M. A. [1 ]
Meenakshi, Dhanalekshmi U. [1 ]
机构
[1] Natl Univ Sci & Technol, Coll Pharm, Muscat, Oman
[2] CSIR NEERI, Nehru Marg, Nagpur, Maharashtra, India
关键词
Drug delivery; targeted therapies; cancer; toxicity; approach; chemotherapy; treatment strategies; QUANTUM DOTS; MULTIDRUG-RESISTANCE; BREAST-CANCER; CHITOSAN NANOPARTICLES; MAGNETIC HYPERTHERMIA; ENHANCED PERMEABILITY; GOLD NANOPARTICLES; CARBON NANOTUBES; LUNG-CANCER; THERAPY;
D O I
10.2174/1381612827666210728105017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mutations and their manifestations in the form of various diseases and disorders result in cancer which is a major cause of human death worldwide. A considerable amount of information is available at the cellular, molecular and genetic levels regarding the occurrence and spread of precarious cancer; yet, there is no cure. The traditional methods of treatment such as chemotherapy, radiotherapy and surgical intervention have shown to be moderately effective and to keep some types of cancer under control, but each modality has its own advantages and disadvantages. In recent years, more advanced methods such as targeted therapies, immunotherapy, and precision medicine are shown to be promising, and these fields continue to expand rapidly along with the conventional methods. This review focuses on the reports of advanced methods of treatment from a scientific standpoint to recognize many new and modern approaches. Selective targeting of the tumour cells by nanoparticle-based novel drug delivery approaches includes the latest innovations in their preparation strategies and applications. The concept of precision medicine and its impact on treatment are highlighted here with the hope of individualised therapy with minimum side effects as a part of ever-expanding treatment strategies. Additional challenges related to cancer treatment like multi-drug resistance and toxicity are also deliberated in brief. Based on the available reports and scientific evidence, better targeted approaches with better quality clinical outcomes and more precise drug delivery to fit individual treatment needs are anticipated in the near future to control this deadly disease.
引用
收藏
页码:4593 / 4609
页数:17
相关论文
共 160 条
  • [1] Liposome: classification, preparation, and applications
    Akbarzadeh, Abolfazl
    Rezaei-Sadabady, Rogaie
    Davaran, Soodabeh
    Joo, Sang Woo
    Zarghami, Nosratollah
    Hanifehpour, Younes
    Samiei, Mohammad
    Kouhi, Mohammad
    Nejati-Koshki, Kazem
    [J]. NANOSCALE RESEARCH LETTERS, 2013, 8
  • [2] Alavi Mehran, 2019, Drug Metabolism and Personalized Therapy, V34, P20180032, DOI 10.1515/dmpt-2018-0032
  • [3] Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
    Alfarouk, Khalid O.
    Stock, Christian-Martin
    Taylor, Sophie
    Walsh, Megan
    Muddathir, Abdel Khalig
    Verduzco, Daniel
    Bashir, Adil H. H.
    Mohammed, Osama Y.
    Elhassan, Gamal O.
    Harguindey, Salvador
    Reshkin, Stephan J.
    Ibrahim, Muntaser E.
    Rauch, Cyril
    [J]. CANCER CELL INTERNATIONAL, 2015, 15
  • [4] [Anonymous], 2008, WORLD CANC REPORT
  • [5] [Anonymous], 2018, ANN COMPLEMENT ALTER
  • [6] [Anonymous], 2019, Cancer Facts Figures for African Americans 2019-2021, P1
  • [7] Fluorescence Tumor-Imaging Using a Thermo-Responsive Molecule with an Emissive Aminoquinoline Derivative
    Araki, Takeru
    Fuchi, Yasufumi
    Murayama, Shuhei
    Shiraishi, Ryoma
    Oyama, Tokimi
    Aso, Mariko
    Aoki, Ichio
    Kobayashi, Shigeki
    Yamada, Ken-ichi
    Karasawa, Satoru
    [J]. NANOMATERIALS, 2018, 8 (10):
  • [8] A side-effect free method for identifying cancer drug targets
    Ashraf, Md. Izhar
    Ong, Seng-Kai
    Mujawar, Shama
    Pawar, Shrikant
    More, Pallavi
    Paul, Somnath
    Lahiri, Chandrajit
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [9] An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
    Attia, Mohamed F.
    Anton, Nicolas
    Wallyn, Justine
    Omran, Ziad
    Vandamme, Thierry F.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (08) : 1185 - 1198
  • [10] Doxil® - The first FDA-approved nano-drug: Lessons learned
    Barenholz, Yechezkel
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) : 117 - 134